A detailed history of Peak6 LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Peak6 LLC holds 29,200 shares of NEO stock, worth $282,948. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,200
Previous 35,500 17.75%
Holding current value
$282,948
Previous $336,000 36.61%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$6.4 - $10.27 $62,816 - $100,800
9,815 Added 61.82%
25,691 $187,000
Q1 2025

May 14, 2025

BUY
$9.09 - $18.61 $144,312 - $295,452
15,876 New
15,876 $150,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.22B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Peak6 LLC Portfolio

Follow Peak6 LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 LLC with notifications on news.